Price T Rowe Associates Inc Ironwood Pharmaceuticals Inc Transaction History

Price T Rowe Associates Inc

  • $816 Billion
  • Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 85,577 shares of IRWD stock, worth $532,288. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85,577
Previous 80,584 6.2%
Holding current value
$532,288
Previous $922,000 19.09%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$8.32 - $15.45 $41,541 - $77,141
4,993 Added 6.2%
85,577 $746,000
Q4 2023

Feb 14, 2024
BUY
$8.79 - $11.51 $74,512 - $97,570
8,477 Added 11.76%
80,584 $922,000
Q3 2023

Nov 14, 2023
BUY
$8.25 - $11.35 $88,786 - $122,148
10,762 Added 17.54%
72,107 $695,000
Q2 2023

Aug 14, 2023
BUY
$10.1 - $11.6 $15,665 - $17,991
1,551 Added 2.59%
61,345 $653,000
Q1 2023

May 15, 2023
SELL
$10.37 - $12.56 $341,183 - $413,236
-32,901 Reduced 35.49%
59,794 $630,000
Q4 2022

Feb 14, 2023
SELL
$9.9 - $12.43 $76,170 - $95,636
-7,694 Reduced 7.66%
92,695 $1.15 Million
Q3 2022

Nov 14, 2022
BUY
$10.14 - $12.38 $91,178 - $111,320
8,992 Added 9.84%
100,389 $1.04 Million
Q2 2022

Aug 15, 2022
SELL
$11.05 - $12.72 $1,690 - $1,946
-153 Reduced 0.17%
91,397 $1.05 Million
Q1 2022

May 16, 2022
SELL
$10.61 - $12.88 $64,370 - $78,142
-6,067 Reduced 6.22%
91,550 $1.15 Million
Q4 2021

Feb 14, 2022
SELL
$10.86 - $13.95 $266,374 - $342,165
-24,528 Reduced 20.08%
97,617 $1.14 Million
Q3 2021

Nov 15, 2021
SELL
$11.92 - $13.92 $127,544 - $148,944
-10,700 Reduced 8.05%
122,145 $1.6 Million
Q2 2021

Aug 16, 2021
SELL
$10.16 - $13.11 $183,581 - $236,884
-18,069 Reduced 11.97%
132,845 $1.71 Million
Q1 2021

May 17, 2021
SELL
$9.04 - $11.86 $200,326 - $262,817
-22,160 Reduced 12.8%
150,914 $1.69 Million
Q4 2020

Feb 16, 2021
BUY
$9.05 - $12.2 $1.57 Million - $2.11 Million
173,074 New
173,074 $1.97 Million

Others Institutions Holding IRWD

# of Institutions
296
Shares Held
170M
Call Options Held
27.1M
Put Options Held
2.28M
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $953M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email